Lexington Vaccine Company Cites Antibody Response

Lexington MA

25 August, 2020

2:59 PM

Description

LEXINGTON, MA — Lexington-based Translate Bio inc. developed an experimental coronavirus vaccine with the French vaccine company Sanofi, and the vaccine is showing high levels of antibodies in early-stage animal studies, according to a regulatory filing obtained by Bloomberg news. Translate Bio is an mRNA therapeutics company partnering with Saofi for the COVID-19 vaccine work — according to Bloomberg news, who broke the story, Sanofi was set to present the data at an event on Tuesday. Read more about this story at Bloomberg News.